Skip to content

13F-HR filed by EcoR1 Capital, LLC

EcoR1 Capital, LLC filed this 13F-HR for the quarter ended 2018-03-31, filed 2018-05-15, with 31 holding rows worth $997,012,000.

Accession
0001140361-18-023901
Filed
2018-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2018

A holdings report, 32 entries on the cover page, a total value of $997,012,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $997,012,000 with VALUE read as thousands by filing date, 13F file number 028-16764. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ASSEMBLY BIOSCIENCES INC045396108COM2,943,165$144,627,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR1,822,575$119,196,000thousands by filing date
FIBROGEN INC31572Q808COM2,002,437$92,513,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK5,885,583$90,815,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock3,766,852$70,628,000thousands by filing date
WAVE LIFE SCIENCES LTD SHSY95308105Stock1,459,072$58,509,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock3,049,312$49,765,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM4,764,447$45,548,000thousands by filing date
MACROGENICS INC556099109COM1,450,606$36,497,000thousands by filing date
ARCUS BIOSCIENCES INC03969F109COM2,236,387$34,530,000thousands by filing date
CELGENE CORP151020904COM385,000$34,346,000thousands by filing datecall
APELLIS PHARMACEUTICALS INC03753U106COM1,056,348$23,356,000thousands by filing date
FIVE PRIME THERAPEUTICS INC.33830X104Common Stock1,240,470$21,311,000thousands by filing date
UROGEN PHARMA LTDM96088105COMMON STOCK402,300$19,990,000thousands by filing date
FIBROGEN INC31572Q908CALL325,000$15,015,000thousands by filing datecall
IMMUNE DESIGN CORP.45252L103Common Stock4,437,600$14,422,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM172,952$14,144,000thousands by filing date
AKEBIA THERAPEUTICS INC00972D105COMMON STOCK1,425,000$13,580,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM3,668,307$13,573,000thousands by filing date
DOVA PHARMACEUTICALS INC25985T102COM429,729$11,654,000thousands by filing date
ATYR PHARMA INC002120103COM3,917,972$10,579,000thousands by filing date
DBV TECHNOLOGIES S A23306J101ADR450,000$10,382,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X908COM CL A667,800$10,305,000thousands by filing datecall
PROTAGONIST THERAPEUTICS74366E102COM1,083,567$9,308,000thousands by filing date
SYNLOGIC INC87166L100COM700,000$6,566,000thousands by filing date
DENALI THERAPEUTICS INC COM24823R105Stock325,000$6,399,000thousands by filing date
RHYTHM PHARMACEUTICALS INC76243J105COM318,564$6,339,000thousands by filing date
CORVUS PHARMACEUTICALS INC221015100COM469,700$5,416,000thousands by filing date
NEWLINK GENETICS CORP651511907COM560,000$4,060,000thousands by filing datecall
KINDRED BIOSCIENCES INC COM494577109Stock248,680$2,151,000thousands by filing date
GERON CORP374163103COM350,000$1,488,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001140361-18-023901this filing2018-05-15acceptance time not in the bulk data set